Literature DB >> 15550015

Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass.

A Lillo-Le Louët1, P Boutouyrie, M Alhenc-Gelas, C Le Beller, I Gautier, M Aiach, D Lasne.   

Abstract

Heparin-induced thrombocytopenia (HIT) occurs in nearly 3% of patients treated with heparin after cardiopulmonary bypass (CPB). HIT carries a risk of severe thrombotic complications, and must be diagnosed rapidly. To identify simple criteria for estimating the probability of HIT after CPB, we retrospectively analyzed the files of 84 patients with suspected HIT after CPB and we analyzed the usefulness of several variables collected at the time of HIT suspicion to estimate HIT probability. HIT was confirmed in 35 cases and ruled out in 49 cases, on the basis of a platelet increment after heparin withdrawal, detection of heparin-dependent antibodies, and absence of other clear cause of thrombocytopenia. A biphasic platelet count from CPB to the first day of suspected HIT, an interval of >/= 5 days from CPB to the first day of suspected HIT, and a CPB duration of </= 118 min were independent risk factors for HIT. These variables were combined to create a post-CPB HIT probability score. The score correctly identified 34/35 HIT patients and 28/49-non-HIT patients. This score, which can be applied as soon as HIT is suspected after CPB, has very good negative predictive value (97%). Prospective studies are required to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550015     DOI: 10.1111/j.1538-7836.2004.00949.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  26 in total

1.  Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia.

Authors:  Nicole L Whitlatch; David F Kong; Ara D Metjian; Gowthami M Arepally; Thomas L Ortel
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 2.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Platelet factor 4/heparin-particle gel immunoassay (PaGIA) is a weak method for heparin-induced thrombocytopenia (HIT) evaluation of post cardio-pulmonary bypass surgery patients.

Authors:  Chezi Ganzel; Jacob Rowe; David Raveh
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

4.  Over-testing for heparin induced thrombocytopenia in hospitalized patients.

Authors:  Shruti Chaturvedi; Ruhail Kohli; Keith McCrae
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

5.  Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia.

Authors:  Allyson M Pishko; Sara Fardin; Daniel S Lefler; Koosha Paydary; Rolando Vega; Gowthami M Arepally; Mark Crowther; Lawrence Rice; Douglas B Cines; Adam Cuker
Journal:  Blood Adv       Date:  2018-11-27

Review 6.  Heparin-induced thrombocytopenia in solid organ transplant recipients: The current scientific knowledge.

Authors:  Volker Assfalg; Norbert Hüser
Journal:  World J Transplant       Date:  2016-03-24

7.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

Authors:  Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon
Journal:  J Extra Corpor Technol       Date:  2018-03

8.  Optical density values correlate with the clinical probability of heparin induced thrombocytopenia.

Authors:  Brendan M Weiss; Nathan M Shumway; Robin S Howard; Lloyd K Ketchum; Thomas J Reid
Journal:  J Thromb Thrombolysis       Date:  2007-11-04       Impact factor: 2.300

Review 9.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally; Thomas L Ortel
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

Review 10.  Diagnosis and management of heparin-induced thrombocytopenia.

Authors:  Grace M Lee; Gowthami M Arepally
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-13       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.